-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RyVhlSKHHrkQ2xQKz3C/jPqk9b9eX/jhm1Mq8H0fMqb/s7+yLhNoyBAtEiphfHMu KkFoLSAbZZK2VbS+ZCssgQ== 0000919574-02-000705.txt : 20020415 0000919574-02-000705.hdr.sgml : 20020415 ACCESSION NUMBER: 0000919574-02-000705 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020311 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN SPECIALTY THERAPEUTICS INC CENTRAL INDEX KEY: 0001049711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330779207 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-53925 FILM NUMBER: 02572578 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142466912 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CONSTABLE LOURDE JOHN CENTRAL INDEX KEY: 0001060522 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 5 RADNOR CORP CENTER STREET 2: 100 MATSONFORD ROAD SUITE 520 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: 6109640750 MAIL ADDRESS: STREET 1: 5 RADNOR CORP CENTER STREET 2: 100 MATSONFORD ROAD SUITE 520 CITY: RADNOR STATE: PA ZIP: 19087 SC 13G/A 1 am202414001ag7.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No.: 3 Name of Issuer: Allergan Specialty Therapeutics, Inc. Title of Class of Securities: Class A Common Stock CUSIP Number: 018494104 (Date of Event Which Requires Filing of this Statement) December 31, 2001 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) /X/ Rule 13d-1(c) / / Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP Number: 018494104 1. Name of Reporting Person I.R.S. Identification No. of Above Person Lourde John Constable, d/b/a Constable Asset Management, Ltd. 2. Check the Appropriate Box if a Member of a Group a. b. X 3. SEC Use Only 4. Citizenship or Place of Organization United States Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power: 0 6. Shared Voting Power: 0 7. Sole Dispositive Power: 0 8. Shared Dispositive Power: 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 0 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares -2- 11. Percent of Class Represented by Amount in Row (9) 0% 12. Type of Reporting Person IN -3- CUSIP Number: 018494104 1. Name of Reporting Person I.R.S. Identification No. of Above Person Constable Partners, L.P. 2. Check the Appropriate Box if a Member of a Group a. b. X 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power: 0 6. Shared Voting Power: 0 7. Sole Dispositive Power: 0 8. Shared Dispositive Power: 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 0 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares -4- 11. Percent of Class Represented by Amount in Row (9) 0% 12. Type of Reporting Person PN -5- This Schedule 13G Amendment No. 3 is being filed to correct a clerical error in a previously filed Schedule 13G Amendment No. 2 (the "Previous Filing") reporting the address of Lourde John Constable doing business as Constable Asset Management, Ltd. and Constable Partners, L.P. (together, the "Reporting Persons"). That address changed on September 1, 2001 and was incorrectly listed in the Previous Filing. Item 1(a) Name of Issuer: Allergan Specialty Therapeutics, Inc. (b) Address of Issuer's Principal Executive Offices: 2525 Dupont Drive Irvine, CA 92612 Item 2(a) - (c). Name, Principal Business Address, and Citizenship of Persons Filing: Lourde John Constable d/b/a Constable Asset Management Constable Partners, L.P. 41 Leopard Road Suite 202 Paoli, Pennsylvania 19301 Mr. Constable - United States citizen Constable Partners, L.P. - Delaware limited partnership (d) Title of Class of Securities: Class A Common Stock (e) CUSIP Number: 018494104 Item 3. If this statement is filed pursuant to Rule 13d-1(b)(1) or 13d-2(b) or (c) check whether the person filing is: (a) / / Broker or dealer registered under Section 15 of the Act, (b) / / Bank as defined in Section 3(a)(6) of the Act, -6- (c) / / Insurance Company as defined in Section 3(a)(19) of the Act, (d) / / Investment Company registered under Section 8 of the Investment Company Act, (e) / / Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940, (f) / / Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund, (g) / / Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G), (h) / / Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act, (i) / / Church plan excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act, (j) / / Group, in accordance with Rule 13d- 1(b)(1)(ii)(H). If this statement is filed pursuant to Rule 13d-1(c), check this box. /X/ Item 4. Ownership. (a) Amount Beneficially Owned: John Constable - 0; Constable Partners, L.P. - 0 (b) Percent of Class: John Constable - 0%; Constable Partners, L.P. - 0% (c) John Constable - 0 shares with shared power to vote or to direct the vote; 0 shares with sole power to vote or to direct the vote; 0 shares with shared power to dispose or to direct the disposition of; 0 shares with the sole power to dispose or to direct the disposition of Constable Partners, L.P. - 0 shares with shared power to vote or to direct the vote; 0 shares with sole power to vote or to direct the vote; -7- 0 shares with shared power to dispose or to direct the disposition of; 0 shares with the sole power to dispose or to direct the disposition of -8- Item 5. Ownership of Five Percent or Less of a Class. This Schedule 13G Amendment No.1 is being filed to report that the Reporting Person is no longer a beneficial owner of greater than 5% of the Class of Securities of the Issuer. Item 6. Ownership of More than Five Percent on Behalf of Another Person. N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company. N/A Item 8. Identification and Classification of Members of the Group. N/A Item 9. Notice of Dissolution of the Group. N/A -9- Item 10. Certification for Rule 13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. CONSTABLE PARTNERS, L.P. By: /s/ Lourde John Constable _____________________________ Lourde John Constable General Partner /s/ Lourde John Constable _____________________________ Lourde John Constable March 11, 2002 -10- Exhibit A AGREEMENT The undersigned agree that this Schedule 13G Amendment No. 3 dated March 11, 2002 relating to the Class A Common Stock of Allergan Specialties Therapeutics, Inc. shall be filed on behalf of the undersigned. CONSTABLE PARTNERS, L.P. By: /s/ Lourde John Constable _____________________________ Lourde John Constable General Partner /s/ Lourde John Constable _____________________________ Lourde John Constable 02414001.AG7 -----END PRIVACY-ENHANCED MESSAGE-----